Outcome of Renal Tumors in Young Adults
Overview
Affiliations
Purpose: Sporadic RCC is rare in young adults. We retrospectively reviewed the outcomes of patients 20 to 40 years old at our institution.
Materials And Methods: Between 1975 and 2004, 2,710 patients were treated surgically for renal masses at our institution. We found 120 patients (4.4%) 20 to 40 years old. We analyzed the clinical presentation, pathological characteristics and outcome of these patients, and compared it to patients older than 40 years.
Results: The mean age of 120 young adults was 34.1 years (range 20.4 to 39.8). Symptomatic presentation was documented in 49.5% of patients. RCC was found in 87 (72.5%) young adults. Young patients generally had a higher rate of organ confined tumors than patients older than 40 years (73.6% vs 59.3%, p <0.05). Histopathological characteristics, tumor size, lymph node metastases and distant metastatic disease did not differ significantly in young and older patients. Women were significantly more likely to have benign lesions (41% vs 20%, p <0.05). Mean followup for 120 patients was 80.6 months and 15 of 87 patients with RCC (17.2%) died of tumor related causes (mean followup 27.5 months). The 10-year cancer specific survival rate was 78% in young adults and 68% in older patients (p = 0.22). Multivariate Cox regression analysis revealed lymph node metastases and tumor differentiation grade as independent prognostic parameters in young patients.
Conclusions: Young patients are more likely to have symptomatic tumors at presentation. Nevertheless, they have more favorable pathological features and a definite trend to superior disease specific survival following surgical treatment. Organ sparing surgery should be considered in young women since benign lesions are frequent found in this population.
Al-Qudimat A, Altahtamoun S, Kilic F, Al-Zoubi R, Al Zoubi M Heliyon. 2024; 10(13):e32822.
PMID: 39035535 PMC: 11259794. DOI: 10.1016/j.heliyon.2024.e32822.
Mousavi S, Najafi M, Aslani A, Fazlollahi A, Yekta Z, Sadri M Sci Rep. 2024; 14(1):11294.
PMID: 38760399 PMC: 11101446. DOI: 10.1038/s41598-024-61748-2.
Kim J, Jung G, Kwak C, Jeong C, Kang S, Hong S PLoS One. 2023; 18(3):e0283483.
PMID: 36996119 PMC: 10062612. DOI: 10.1371/journal.pone.0283483.
Renal Cell Carcinoma as an Incidental Finding in Firefighters: A Case Series.
Geiger K, Wright T, Deters L Cureus. 2020; 12(7):e9259.
PMID: 32821605 PMC: 7431987. DOI: 10.7759/cureus.9259.
Alkazemi M, Dionise Z, Jiang R, Wolf S, Pomann G, Tracy E J Pediatr Surg. 2019; 54(11):2343-2347.
PMID: 31178166 PMC: 6879817. DOI: 10.1016/j.jpedsurg.2019.05.018.